Journals / The Anatolian Journal of Cardiology / 2019 / Cilt: 22 - Sayı: 3

First case of cardiac amyloidosis presenting as right atrial mass

Pages
152–154
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Intracardiac masses can cause symptoms such as embolization, heart failure,valvular regurgitation, arrhythmia, and pericardial effusion.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Intracardiac masses can be encountered during the evaluation of patients with cardiac symptoms; myxoma, primary and metastatic neoplasms, thrombus, and vegetation should be considered in the differential diagnosis in such cases.
📊
Key Findings & Data:Intracardiac masses can be encountered during the evaluation of patients with cardiac symptoms; myxoma, primary and metastatic neoplasms, thrombus, and vegetation should be considered in the differential diagnosis in such cases.
💡
Conclusion & Impact:Intracardiac masses can cause symptoms such as embolization, heart failure,valvular regurgitation, arrhythmia, and pericardial effusion.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Intracardiac masses can be encountered during the evaluation of patients with cardiac symptoms; myxoma, primary and metastatic neoplasms, thrombus, and vegetation should be considered in the differential diagnosis in such cases. Intracardiac masses can cause symptoms such as embolization, heart failure,valvular regurgitation, arrhythmia, and pericardial effusion.

🔖

Cite This Article

ACIBUCA, A., OKAR, S., CANPOLAT, T., KOÇ, Z., GÜLLÜ, H. (2019). First case of cardiac amyloidosis presenting as right atrial mass. The Anatolian Journal of Cardiology, Cilt: 22 - Sayı: 3, 152–154. https://ajindex.com/articles/367219

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Diaz A, Di Salvo C, Lawrence D, Hayward M. Left atrial and right ventricular myxoma: an uncommon presentation of a rare tumour. Interact Cardiovasc Thorac Surg 2011; 12: 622–3
  2. Kapoor P, Thenappan T, Singh E, Kumar S, Greipp PR. Cardiac amyloidosis: a practical approach to diagnosis and management. Am J Med 2011; 124: 1006-15
  3. Dubrey SW, Cha K, Skinner M, LaValley M, Falk RH. Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes. Heart 1997; 78: 74-82
  4. Gertz MA, Comenzo R, Falk RH, Fermand JP, Hazenberg BP, Hawkins PN, et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18–22 April 2004. Am J Hematol 2005; 79: 319-28
  5. Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med 2003; 349: 583-96
  6. Tuzovic M, Yang EH, Baas AS, Depasquale EC, Deng MC, Cruz D, et al. Cardiac Amyloidosis: Diagnosis and Treatment Strategies. Curr Oncol Rep 2017; 19: 46.